Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Preferred Shares (2023 - 2025)

Xenetic Biosciences' Preferred Shares history spans 3 years, with the latest figure at $1454.0 for Q4 2025.

  • For Q4 2025, Preferred Shares fell 19.4% year-over-year to $1454.0; the TTM value through Dec 2025 reached $1454.0, down 19.4%, while the annual FY2025 figure was $1454.0, 19.4% down from the prior year.
  • Preferred Shares reached $1454.0 in Q4 2025 per XBIO's latest filing, down from $1804.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $1804.0 in Q2 2023 to a low of $970.0 in Q1 2023.
  • Average Preferred Shares over 3 years is $1635.8, with a median of $1804.0 recorded in 2023.
  • Peak YoY movement for Preferred Shares: surged 85.98% in 2024, then dropped 19.4% in 2025.
  • A 3-year view of Preferred Shares shows it stood at $1804.0 in 2023, then changed by 0.0% to $1804.0 in 2024, then decreased by 19.4% to $1454.0 in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Preferred Shares are $1454.0 (Q4 2025), $1804.0 (Q3 2025), and $1804.0 (Q2 2025).